Kvinneklinikken KK
Hjertekrampe Rollespill
➡ ♥♥♥ Link: Angina hos kvinner
➡ ♥♥♥ Link: https://dating18plus.ru/Laura1996
Low-dose colchicine for secondary prevention of cardiovascular disease. Ugeskr Læger 2000; 162: 3437-42. Bruises often become more prominent as time lapses, resulting in additional size and swelling, and may grow to a large size over the course of the hours after the injury that caused the bruise was inflicted.
Det kan delvis ha sammenheng med at kvinner i gjennomsnitt er en del eldre enn menn når de får slike plager, og at plagene har en tendens til å bli mer diffuse hos eldre. Legen vurderer om du treng raskare behandling. Avleiring av blod og kalk De bakenforliggende årsakene er de samme som ved hjerteinfarkt; kolesterol- og kalkavleiringer i blodårene. Episoderne ligner meget hinanden og er af kort varighed.
Angina symptomer hos kvinner - Etter dette må du registrere deg på ny. Strålingsdosen ved stressmyokardperfusjonsscintigrafi er relativt høy, ca.
Smertene melder seg typisk ved fysisk anstrengelse og forsvinner ved hvile. Dersom det er små forandringer, kan det hende at smerten kun kjennes ved svært harde belastninger. Når forandringene i blodårene er uttalte, kan selv små pulsøkninger føre til smerter. Som regel vil smerten ved angina pectoris fortone seg som en klemmende smerte midt i brystet. Smerten kan være alt fra mild til sterk. Andre beskriver smerten som brennende, eller som en tung vekt som er plassert over brystkassen. Det er heller ikke uvanlig, men ingen lovmessighet i, at smerten stråler til skulder og arm særlig på venstre side eller nakke. Det kan i enkelte tilfeller være vanskelig å peke ut akkurat hvor smerten stammer fra, og noen kan oppleve det som om smerten kommer fra øvre del av magen, ryggen eller kjeven. Kvinner kan oftere enn menn presentere atypisk angina med variabel smerteterskel, smerter under brystene, hjertebank eller skarpe, stikkende smerter. Andre symptomer som kan forekomme ved angina pectoris-anfall er kortpustethet, ørhet og besvimelsestendens, svetting, eventuelt kaldsvetting og kvalme. Huden kan bli blek, og det er ikke uvanlig med angst eller nervøsitet. N Engl J Med 2005; 352: 2524-33. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: an intravascular ultrasound study. Prognostic value of coronary vascular endothelial dysfunction. Controversies in stable coronary artery disease. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung and Blood Institute. Pathophysiology and management of patients with chest pain and normal coronary arteriograms cardiac syndrome X. Forebyggende livsstilsråd mot hjerte- og karsykdommer i primærhelsetjenesten. Tidsskr Nor Lægeforen 2000; 120: 2656-60. Abdominal obesity is associated with increased risk of acute coronar events in men. Eur Heart J 2002; 23: 706-13. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: A meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med 2007; 167: 1720-8. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study. Obesity accelerates the progression of coronary atherosclerosis in young men. Long-term Exercise and Atherogenic Activity og Blood Mononuclear Cells inPersons at Risk of Developing Ischemic Heart Disease. Psychosocial factors in the primary and secondary prevention of coronary heart disease: a systematic review. Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 2005; 353: 1454-62. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus. Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 2000; 342:154-60. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006; 354: 1578-88. Epidemiology of coronary heart disease in women. Prog Cardiovasc Dis 2004; 46: 287-95. Incremental prognostic value of the exercise electrocardiogram in the initial assessment of patients with suspected angina: cohort study. Screening for coronary heart disease: Recommendation statement. N Engl J Med 2007; 356: 1503-16. A randomized trial of terapies for type 2 diabetes and coronary arterry disease. N Engl J Med 2009; 360: 2503-15. Meta-analysis: Effects of percutaneous coronary intervention versus medical therapy on angina relief. Ann Intern Med 2010; 152: 370-9. Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease. Metaanalysis of randomized clinical trials of the arterial grafting and stenting era. Percutaneous coronary interventions for non-acute coronary artery disease: quantitative 20-year synopsis and a network meta-analysis. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Comparative effectiveness of revascularization strategies. N Engl J Med 2012; : doi:10. Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina. J Am Coll Cardiol 2003; 41: 159-68. A randomised, multicentre, double blind, placebo controlled trial to evaluate the efficacy and safety of cilostazol in patients with vasospastic angain. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 145-53. Erratum, N Engl J Med 2000; 342: 748. J Am Coll Cardiol 2004; 43: 1743-51. Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. Meta-Analysis of Trials on Mortality After Percutaneous Coronary Intervention Compared With Medical Therapy in Patients With Stable Coronary Heart Disease and Objective Evidence of Myocardial Ischemia. Methods of coronary revascularization - things may not be as they seem. N Engl J Med 2005; 352: 2235-7. Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials. Physician advice for smoking cessation. Cochrane Database of Systematic Reviews 2013, Issue 5. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Tobacco smoke exposure is associated with the metabolic syndrome in adolescents. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction. Final report of the Lyon Diet Heart Study. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomized trials by the coronary artery bypass graft surgery trialists collaboration. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2002; 112: 298-304. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review. Exercise training in coronary artery disease and coronary vasomotion. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database of Systematic Reviews 2012, Issue 5. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis. Cardioselective beta-blockers for reversible airway disease. Cochrane Database of Systematic Reviews 2002, Issue 4. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med 2017. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005; 352: 1425-35. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med 2004; 351: 2058-68. Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: Systematic review and meta-analysis of randomized trials. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R and Dagenais G. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 145-53. Ranolazine for stable angina pectoris. Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial. Low-dose colchicine for secondary prevention of cardiovascular disease. J Am Coll Cardiol 2013 ; 61: 404-10. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. N Engl J Med 2017. Invasiv behandling af angina pectoris. Ugeskr Læger 2000; 162: 3437-42. Chronic stable angina: treatment options. Dietary Fiber, Weight Gain, and Cardiovascular Disease Risk Factors in Young Adults. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 2003; 348: 1537 - 44. Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. Trening etter perkutan koronar intervensjon - en undervurdert behandlingsmulighet?. Tidsskr Nor Lægeforen 2007; 127: 1365-7. Koronar angioplastikk hos eldre pasientar. Tidsskr Nor Lægeforen 2002; 122: 1266-9. Guidelines for coronary artery bypass graft surgery: Executive summary and recommendations. Er arteriegraft bedre enn venegraft?. Tidsskr Nor Lægeforen 2002; 122: 591. Enhanced external counterpulsation til behandling af refraktær angina pectoris. Ugeskr Læger 2013; 175: 116. Ryggmärgsstimulering vid angina - var står vi idag? Tidsskr Nor Lægeforen 1999; 119:3582-6. Collaborative overview of randomised trials of antiplatelet therapy - I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006; 354: 1706-17. Effects of prophylactic antiarrhytmic drug therapy in acute myocardial infarction. Ivabradine for patients with stable coronary artery disease. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study 4S. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation 1989; 80: 234 - 44. The efficacy and safety of exercise programs in cardiac rehabilitation. Med Sci Sports Exerc 1994; 26: 815 - 23. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. Antioxidant vitamin supplementation in 20. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005; 142: 37-46. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: A randomized controlled trial. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database of Systematic Reviews 2011, Issue 7. Betydningen af fysisk træning som led i rehabilitering af patienter med iskæmisk hjertesygdom. Ugeskr Læger 2003; 165: 3227-8. Retningslinier for diagnostik og behandling. Ugeskr Læger 2001; 163 suppl 3. Randomised trials of secundary prevention programmes in coronary heart disease: systemic review. Secondary prevention clinics for coronary heart disease: randomised trial of effect on health. Secondary prevention clinics for coronary heart disease: four year follow up of a randomised controlled trial in primary care. Secondary prevention clinics for coronary heart disease: a 10-years follow-up of a randomised controlled trial in primary care. Depressive symptoms, helath behaviors, and risk of cardiovascular events in patients with coronary heart disease. Dersom du er syk eller trenger medisinsk hjelp av andre grunner, bør du oppsøke lege. Alle slike innlegg vil bli slettet.